scholarly article | Q13442814 |
P819 | ADS bibcode | 2014PNAS..111.4215R |
P356 | DOI | 10.1073/PNAS.1320924111 |
P932 | PMC publication ID | 3964059 |
P698 | PubMed publication ID | 24591636 |
P5875 | ResearchGate publication ID | 260486364 |
P2093 | author name string | Masato Tanaka | |
Andrew L Mellor | |||
David H Munn | |||
Phillip Chandler | |||
Kapil Chaudhary | |||
Haiyun Liu | |||
Henrique P Lemos | |||
Tracy L McGaha | |||
Buvana Ravishankar | |||
Rahul Shinde | |||
Jillian Bradley | |||
P2860 | cites work | Immune tolerance after delivery of dying cells to dendritic cells in situ | Q24673068 |
Induction of anterior chamber-associated immune deviation requires an intact, functional spleen | Q24683730 | ||
Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4 | Q28259171 | ||
Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor | Q28595009 | ||
Differential antigen processing by dendritic cell subsets in vivo | Q29615177 | ||
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF | Q29615685 | ||
Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice | Q29622850 | ||
Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans. | Q33361113 | ||
CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells | Q33623556 | ||
The male-specific histocompatibility antigen, H-Y: a history of transplantation, immune response genes, sex determination and expression cloning | Q34425408 | ||
Regulation of macrophage-derived chemokine (MDC, CCL22) production | Q34998186 | ||
Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets | Q35142798 | ||
Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells. | Q35175866 | ||
CD103+ pulmonary dendritic cells preferentially acquire and present apoptotic cell-associated antigen | Q35208349 | ||
Tolerance to apoptotic cells is regulated by indoleamine 2,3-dioxygenase. | Q35844935 | ||
Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens | Q35901015 | ||
In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination | Q36786874 | ||
Regulatory T cells in tumor immunity | Q37762224 | ||
O death where is thy sting? Immunologic tolerance to apoptotic self | Q38078769 | ||
Novel subset of CD8{alpha}+ dendritic cells localized in the marginal zone is responsible for tolerance to cell-associated antigens. | Q38355730 | ||
Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion | Q42326715 | ||
Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice | Q42587994 | ||
Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells | Q42947524 | ||
Dermal regulatory T cells display distinct migratory behavior that is modulated during adaptive and innate inflammation | Q43965901 | ||
Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation | Q44556007 | ||
Potent and orally bioavailable CCR4 antagonists: Synthesis and structure-activity relationship study of 2-aminoquinazolines | Q46199266 | ||
Marginal zone macrophages suppress innate and adaptive immunity to apoptotic cells in the spleen. | Q50541519 | ||
Apoptotic cells induce tolerance by generating helpless CD8+ T cells that produce TRAIL. | Q50696330 | ||
A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens. | Q50993058 | ||
Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. | Q51798642 | ||
CCR4 dependent migration of Foxp3+ Treg cells to skin grafts and draining lymph nodes is implicated in enhanced graft survival in CD200tg recipients. | Q53217292 | ||
Immunosuppressive effects of apoptotic cells | Q59060221 | ||
Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide | Q73688337 | ||
Presentation of the HPV16E7 protein by skin grafts is insufficient to allow graft rejection in an E7-primed animal | Q73704307 | ||
Origin of regulatory T cells with known specificity for antigen | Q74381747 | ||
Restoration of tolerance in lupus by targeted inhibitory receptor expression | Q81340901 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | macrophage | Q184204 |
apoptotic process | Q14599311 | ||
P304 | page(s) | 4215-4220 | |
P577 | publication date | 2014-03-03 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Marginal zone CD169+ macrophages coordinate apoptotic cell-driven cellular recruitment and tolerance | |
P478 | volume | 111 |
Q35691201 | Amino acid metabolism inhibits antibody-driven kidney injury by inducing autophagy. |
Q28385358 | Apoptotic cell responses in the splenic marginal zone: a paradigm for immunologic reactions to apoptotic antigens with implications for autoimmunity |
Q88671353 | Apoptotic cell-induced AhR activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mice and humans |
Q46819845 | Apoptotic cells ameliorate chronic intestinal inflammation by enhancing regulatory B-cell function. |
Q35988832 | B Cell-Intrinsic IDO1 Regulates Humoral Immunity to T Cell-Independent Antigens |
Q38685166 | CD169 Expressing Macrophage, a Key Subset in Mesenteric Lymph Nodes Promotes Mucosal Inflammation in Dextran Sulfate Sodium-Induced Colitis |
Q58707686 | CD169 Macrophages Capture and Dendritic Cells Instruct: The Interplay of the Gatekeeper and the General of the Immune System |
Q49592881 | Chemo-Immunotherapy: Role of Indoleamine 2,3-Dioxygenase in Defining Immunogenic Versus Tolerogenic Cell Death in the Tumor Microenvironment |
Q40093361 | Chronic Brucella Infection Induces Selective and Persistent Interferon Gamma-Dependent Alterations of Marginal Zone Macrophages in the Spleen. |
Q38240144 | Clearance of Apoptotic Bodies, NETs, and Biofilm DNA: Implications for Autoimmunity |
Q97067698 | Co-treatments to Boost IDO Activity and Inhibit Production of Downstream Catabolites Induce Durable Suppression of Experimental Autoimmune Encephalomyelitis |
Q38790504 | Concise Review: Apoptotic Cell-Based Therapies-Rationale, Preclinical Results and Future Clinical Developments. |
Q36880118 | Concise Review: Mechanisms Behind Apoptotic Cell-Based Therapies Against Transplant Rejection and Graft versus Host Disease |
Q28394035 | Critical role of CCL22/CCR4 axis in the maintenance of immune homeostasis during apoptotic cell clearance by splenic CD8α(+) CD103(+) dendritic cells |
Q27022855 | Cytosolic DNA sensing via the stimulator of interferon genes adaptor: Yin and Yang of immune responses to DNA |
Q43135357 | Engulfment of activated apoptotic cells abolishes TGF-β-mediated immunoregulation via the induction of IL-6. |
Q28588565 | Enhanced efferocytosis by dendritic cells underlies memory T-cell expansion and susceptibility to autoimmune disease in CD300f-deficient mice |
Q36607908 | Extracellular traps and macrophages: new roles for the versatile phagocyte. |
Q34512092 | IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance |
Q39294822 | IDO, PTEN-expressing Tregs and control of antigen-presentation in the murine tumor microenvironment |
Q47836812 | IDO1 in cancer: a Gemini of immune checkpoints. |
Q91765452 | Identification and isolation of splenic tissue-resident macrophage sub-populations by flow cytometry |
Q38568300 | Immune Regulation by Dead Cell Clearance |
Q91272360 | Immune control by amino acid catabolism during tumorigenesis and therapy |
Q36040281 | Interferon-induced mechanosensing defects impede apoptotic cell clearance in lupus |
Q64087548 | Lymph Node Subcapsular Sinus Macrophages as the Frontline of Lymphatic Immune Defense |
Q38807625 | Macrophage Subset Expressing CD169 in Peritoneal Cavity-Regulated Mucosal Inflammation Together with Lower Levels of CCL22. |
Q35646486 | Much More than M1 and M2 Macrophages, There are also CD169(+) and TCR(+) Macrophages |
Q48666099 | Multipeptide-coupled nanoparticles induce tolerance in 'humanised' HLA-transgenic mice and inhibit diabetogenic CD8+ T cell responses in type 1 diabetes |
Q58699773 | Pleiotropic Impacts of Macrophage and Microglial Deficiency on Development in Rats with Targeted Mutation of the Locus |
Q35813976 | Roles of B Cell-Intrinsic TLR Signals in Systemic Lupus Erythematosus. |
Q38293111 | STING, nanoparticles, autoimmune disease and cancer: a novel paradigm for immunotherapy? |
Q30278837 | Sphingosine 1-Phosphate Receptor 3-Deficient Dendritic Cells Modulate Splenic Responses to Ischemia-Reperfusion Injury |
Q26781264 | Splenic Macrophage Subsets and Their Function during Blood-Borne Infections |
Q26851647 | Tempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cells |
Q53250751 | The CD169 sialoadhesin molecule mediates cytotoxic T-cell responses to tumour apoptotic vesicles. |
Q37423348 | The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer |
Q36394790 | The Spleen: A Hub Connecting Nervous and Immune Systems in Cardiovascular and Metabolic Diseases |
Q36008229 | The amino acid sensor GCN2 inhibits inflammatory responses to apoptotic cells promoting tolerance and suppressing systemic autoimmunity |
Q46772183 | Therapeutic application of T regulatory cells in composite tissue allotransplantation. |
Q55035002 | Tumor-Derived Apoptotic Vesicles: With Death They Do Part. |
Search more.